NEW YORK, NY / ACCESS Newswire / September 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Lesaka Technologies, Inc. ("Lesaka Technologies, Inc.") (NASDAQ:LSAK) concerning possible violations of federal securities laws. Lesaka disclosed in a filing on September 10, 2025, with the U.S. Securities and Exchange Commission ("SEC") that […]

NEW YORK, NY / ACCESS Newswire / September 17, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=167909&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Lyno AI Officially Announces Presale Expansion Following Strong Early Demand GlobeNewswire September 17, 2025 ROAD TOWN, British Virgin Islands, Sept. 17, 2025 (GLOBE NEWSWIRE) — On September 17, 2025, Lyno AI formally states the extension of the presale phase after an impressive demand during the Early Bird round. The project has sold 637,520 tokens at

Investors sitting on appreciated assets are seeding Exchange Traded Funds (ETFs) via a section 351 ETF Exchange,as they look to defer capital gains taxes, potentially keeping more assets invested and compounding for longer. A 351 exchange is a strategic way for high net worth investors to transfer a diversified portfolio of assets, typically individual stocks,

The laboratories of Dr. Kevin Bender and Dr. Nadav Ahituv at the University of California, San Francisco, today announced the publication of preclinical proof-of-concept data demonstrating that CRISPR activation restores SCN2A expression and ameliorates disease-related phenotypes in mouse and human models of SCN2A-haploinsufficiency. The study, published today in Nature, represents a major advance for the

New output-based model leverages AI to cut migration timelines by up to 50%, embed resiliency, and deliver cost-optimized AWS foundations. Caylent, an AWS Premier Tier AWS Partner and leader in cloud modernization and AI-driven delivery, today announced the launch of Caylent Accelerate for Cloud Migration, a new approach for helping customers migrate to Amazon Web

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanex Building Products Corporation ("Quanex" or "the Company") (NYSE:NX). Investors who purchased Quanex securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Soleno Therapeutics, Inc. ("Soleno" or "the Company") (NASDAQ:SLNO). Investors who purchased Soleno securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SLNO.

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agios Pharmaceuticals, Inc. ("Agios" or "the Company") (NASDAQ:AGIO). Investors who purchased Agios securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AGIO.

Los Angeles, CA, Sept. 17, 2025 (GLOBE NEWSWIRE) — In 2025, Synaptigen has quickly emerged as a standout brain health supplement for adults seeking sharper focus and long-term cognitive support. With digital fatigue, constant information overload, and inflammation from modern lifestyles becoming everyday challenges, this pineal-focused formula is designed to restore balance and mental clarity–without